Our Team
Rima Helou- Founder
Doctor of pharmacy with advanced business education from world-renowned institutions such as INSEAD - France & with an impressive background & successful track record of over 20 years of experience in general management & oncology business management in the Middle East region. As an expert in this field, she shared her knowledge as a lecturer in top universities (e.g. St Joseph University) & has launched a free online mentorship program during the pandemic where she actively supports young talents in the pharma field, reflecting her dedication to knowledge-sharing and empowering future leaders in the field. Pioneering the launch of innovative genomic solutions was an additional achievement that underscored her commitment to advancing precision medicine and transforming healthcare across the region.
"Working with passion can achieve your 5-years plan in year 1. It's all about the heart!"
Marie Najjar- Business Manager
Marie holds a Doctorate in Pharmacy from the Lebanese University.
She has more than 20 years of experience in the business management field of different pharmaceutical areas. She has recently accessed the oncogenomic field with high level of commitment to bring innovative solutions to the territories we cover.
"Your genes define your beauty, it's in your hands to preserve it and keep it glowing".
Mohamed Wasfy- Medical Advisor
Dr. Wasfy holds a medical doctorate , master degree in physiology from faculty of medicine Al Azhar University, Diploma of train of the trainer and fellowship in health economics and market access from Wifor institute-Germany, with over 10 years of experience in the medical management of onco-genomic operations.
"Opportunities don't happen, you create them".
Areas of Specialty
Oncology
Our expertise in oncology lies at the intersection of advanced genomics and precision medicine. While partnering with international reference providers, we offer comprehensive genomic testing and molecular profiling services that support clinicians in identifying targeted therapies, monitoring disease progression, and making informed treatment decisions. In addition, we design and deliver tailored oncology programs for the pharmaceutical industry, research institutions, and other healthcare stakeholders. By leveraging the latest technologies and scientific insights, we aim to enhance cancer diagnosis, improve patient outcomes, and bring personalized oncology care to the forefront.